昭衍新药
(603127)
| 流通市值：106.55亿 | | | 总市值：126.73亿 |
| 流通股本：6.30亿 | | | 总股本：7.50亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2024-05-17 | 172.10万 | 0.84% | 672.66万 | 3.30% | 163.55万 | 0.80% | -1008.30万 | -4.94% |
| 2024-05-16 | -577.76万 | -2.56% | 494.10万 | 2.19% | 894.71万 | 3.96% | -811.05万 | -3.59% |
| 2024-05-15 | 16.22万 | 0.07% | 413.60万 | 1.74% | -690.50万 | -2.90% | 260.68万 | 1.10% |
| 2024-05-14 | 537.19万 | 1.34% | 731.14万 | 1.82% | -4481.86万 | -11.15% | 3213.54万 | 7.99% |
| 2024-05-13 | 1049.71万 | 2.23% | -526.49万 | -1.12% | 931.04万 | 1.98% | -1454.25万 | -3.09% |
| 2024-05-10 | -1580.62万 | -4.88% | -1696.69万 | -5.24% | -91.41万 | -0.28% | 3368.72万 | 10.41% |
| 2024-05-09 | -344.15万 | -0.96% | -380.83万 | -1.07% | 240.29万 | 0.67% | 484.69万 | 1.36% |
| 2024-05-08 | -1097.35万 | -2.40% | 203.31万 | 0.44% | -990.35万 | -2.17% | 1884.40万 | 4.12% |
| 2024-05-07 | -3854.59万 | -6.38% | -1698.18万 | -2.81% | -100.24万 | -0.17% | 5653.01万 | 9.36% |
| 2024-05-06 | 6758.61万 | 9.41% | 2655.06万 | 3.69% | -3376.45万 | -4.70% | -6037.22万 | -8.40% |